Bio-Rad Laboratories, Inc.Class A

BIONYSEUSD
356.26 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
356.36
0.10 (0.03%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
356.36
0.10 (0.03%)
🔴Market: CLOSED

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $356.26. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 14, 2026.

Open?$361.06
High?$362.49
Low?$355.07
Prev. Close?$356.26
Volume?173.8K
Avg. Volume?292.4K
VWAP?$358.16
Rel. Volume?0.59x
Bid / Ask
Bid?$343.33 × 40
Ask?$369.59 × 40
Spread?$26.26
Midpoint?$356.46
Valuation & Ratios
Market Cap?9.5B
Shares Out?21.7M
Float?18.1M
Float %?83.4%
P/E Ratio?42.83
P/B Ratio?1.33
EPS?$8.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
9.5B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
84
Momentum?
48
Short Sent.?
45
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.52Safe
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.80%Elevated
Short Interest?1.4M
Days to Cover?4.3
Free Float18.1M
Avg Daily Volume329.4K
Settlement Date2026-07-31
Financial Health
Current Ratio?3.14Strong
Quick Ratio?2.33Strong
Cash Ratio?0.54Adequate
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
61/100
P/E?
Peers
45
S&P
16
42.8PRICEY
P/B?
Peers
91
S&P
91
1.33CHEAP
P/S?
Peers
82
S&P
41
3.68FAIR
P/FCF?
Peers
64
S&P
35
27.0FAIR
EV/EBITDA?
Peers
18
S&P
3
45.2HIGH
EV/Sales?
Peers
82
S&P
48
3.94FAIR
Returns & Efficiency
ROE?
Peers
18
S&P
18
3.1%WEAK
ROA?
Peers
27
S&P
21
2.2%WEAK
Cash Flow & Enterprise
FCF?$353.1M
Enterprise Value?$10.2B
Fundamentals ratios updated end of day